Page last updated: 2024-09-04

hre 664 and Bacterial Disease

hre 664 has been researched along with Bacterial Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauernfeind, A; Jungwirth, R; Schweighart, S1
Isert, D; Johnson, C; Klesel, N; Limbert, M; Schrinner, E; Seibert, G1

Other Studies

2 other study(ies) available for hre 664 and Bacterial Disease

ArticleYear
In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 24 Suppl A

    Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Ceftazidime; Culture Media; Enterobacteriaceae; Germany, West; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa

1989
HRE 664, a new parenteral penem. II. Evaluation of the pharmacokinetic behavior and the chemotherapeutic activity in animals.
    The Journal of antibiotics, 1987, Volume: 40, Issue:8

    Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Infections; Biological Assay; Cefotaxime; Dogs; Lactams; Macaca; Mice; Rats

1987